Inhibition of DNMT1 has been proposed as an adjuvant therapeutic approach to overcome ovarian cancer chemoresistance.6 However, the effect of DNMT regulation on glioblastoma chemoresistance has not been well defined. This evidence concerns the gene DNMT1 and ovarian carcinoma.